BMAL1 and neoplasm: As described above, BMAL1 influences tumor progression by regulating the inflammatory response, in agreement with the findings of Liu et al.156 indicating that circadian rhythm disruption leads to impaired regulatory B cell function and apoptosis of CD4+ T cells in the intestinal epithelium, and subsequently enteritis progression and CRC occurrence.